Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 04-2017 | 01-2017 | 10-2016 | 07-2016 | 04-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,877 | 1,400 | 2,488 | 2,049 | 2,612 |
| Marketable Securities | 2,250 | 600 | 750 | 1,900 | 2,150 |
| TOTAL | $5,192 | $2,069 | $3,400 | $4,006 | $4,801 |
| Non-Current Assets | |||||
| PPE Net | 150 | 160 | 157 | 163 | 171 |
| Intangibles | 1,908 | 1,990 | 2,071 | 2,152 | 2,234 |
| TOTAL | $2,058 | $2,150 | $2,228 | $2,316 | $2,404 |
| Total Assets | $7,250 | $4,219 | $5,628 | $6,321 | $7,206 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | 3,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 660 | 724 | 373 | 532 | 707 |
| Accrued Expenses | N/A | N/A | 96 | N/A | N/A |
| TOTAL | $3,660 | $3,724 | $469 | $532 | $707 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 4,313 | 4,172 | 4,071 | 3,939 |
| TOTAL | $N/A | $4,313 | $4,172 | $4,071 | $3,939 |
| Total Liabilities | $3,660 | $8,037 | $4,641 | $4,603 | $4,646 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,120 | 8,758 | 8,752 | 8,748 | 8,740 |
| Common Shares | 117 | 88 | 88 | 88 | 87 |
| Retained earnings | -152,594 | -152,755 | -151,165 | -150,118 | -149,014 |
| Other shareholders' equity | 0 | 0 | 14 | 14 | 14 |
| TOTAL | $3,589 | $-3,819 | $988 | $1,718 | $2,560 |
| Total Liabilities And Equity | $7,249 | $4,219 | $5,628 | $6,321 | $7,206 |